Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.50p +1.11% 45.50p 45.00p 46.00p 45.50p 45.50p 45.50p 268,990 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -7.2 -4.5 - 93

Futura Medical Share Discussion Threads

Showing 16951 to 16974 of 17200 messages
Chat Pages: 688  687  686  685  684  683  682  681  680  679  678  677  Older
DateSubjectAuthorDiscuss
04/7/2019
16:32
The point of a trial is, surely, that you don't get news until it's complete and the results fully analysed. Meantime the excitement of rubbing one's member with gel is bound to produce a few false positives in the interim, one would have thought.
glavey
04/7/2019
15:50
good or bad
glasgow13
04/7/2019
14:58
Almost 100% upside on Liberum's current fair value at 60p. The upside is 140/280p. News can come anytime.
j777j
04/7/2019
14:43
thats the name of the game - you pays your money and makes your choice ;-)
ragnarr
04/7/2019
14:38
And this pot of gold... Sure thing is it?!
5oletrader
04/7/2019
14:33
too many long term holders here because of the pot of gold at the end - imo will settle 35/40 for a bit
ragnarr
04/7/2019
14:27
Up over 600% in 6 months - Think about it
5oletrader
04/7/2019
13:25
Struggling to break 40p and looks like styling here for a bit
ragnarr
04/7/2019
12:40
"What an opportunity that was" Clearly not many thought so at the time. Placing ended up on Primary Bid and Open Offer uptake circa just 25%. Makes you wonder why so many apparently got it all so wrong, doesn't it?
glavey
04/7/2019
10:36
FUM share price is very strong in last few days , i think FUM got some term sheet(s) so a Deal or even Takeover to be closed quickly after Phase 3 readout if successful . £1+ before year end If everything goes well .STROOOOOOONG BUY
bioking
04/7/2019
10:13
ohh... if everything goes to plan over the next few years that forecast will be VERY conservative :-)
ragnarr
04/7/2019
09:48
Each med dose cost 25 cents. Each med dose $5 retail x number of doses each man takes a year = big numbers. "Most of today's licensing agreements are based on the payment of a royalty to the licensor by the licensee. The royalty is a percentage based on a sales price of the goods (the wholesale price if the product is sold at wholesale and the retail price if it is sold at retail.)" According to the last report by Singer,Futura is expected to get a 15% royalty rate. That is on top of $90 million in upfront and milestone payments. Liberum's 140p forecast could yet look rather conservative.
j777j
03/7/2019
16:41
300 million men worldwide and counting.
j777j
03/7/2019
16:30
Up to half of men under 50 suffer from erectile dysfunction, research claims https://www.independent.co.uk/news/health/erectile-dysfunction-impotence-rates-viagra-causes-heart-disease-research-a8985216.html
keifer derrin
03/7/2019
14:31
note to self - spell check!
ragnarr
03/7/2019
14:30
I think we ate past the stage of gamble - even if Med2005 doesnt come off (although looking increasingly unlikely) there is still TPR100 that has been submitted for marketing approval.Ss a very regular user of Volterol due to a chronic back condition the option of a faster reacting gell with a larger dose of diclofenic (1.16% vs 1.86%) is an absolute no btainer The Global market for this type of pain relaif (NAISDs) is 2.9 billion USD.
ragnarr
03/7/2019
12:54
"Thats why Investors should never invest in early stage pharma stock ony in those who have already phase 3 programs ongoing and are close to clinical results if you like to make money." What a nonsense. Without early stage investors there wouldn't be any Phase III programs to back
markacus
03/7/2019
12:44
major breakout to 50p and higher could start anytime now
bioking
03/7/2019
10:03
Getting into heady territory now.Approval add a zero at the end, failure take a zero off the end. High stakes but..........GLA
jerseymike
03/7/2019
09:47
buyout or big partner deal BEFORE phase 3 readout still possible = £1++ soon .Potential BEST ED drug out there for a long time
bioking
03/7/2019
09:23
lets see if it can break the 40p and get to the next 50p barrier - its not a matter of if - just when :-)
ragnarr
03/7/2019
07:29
What an opportunity that was. Especially when the Ceo two days ago said they have had "Huge interest." Then look at the Almost $13 billion marketplaces they are addressing,with the med and pain gels. Another judge of success to me, will be when the share price exceeds the 90p all time highs set back in 2016,therefore redeeming all long term shareholders. Given Liberum's maximum success scenario of 140p,90p is quite achievable. So hopefully everyone at least gets their money back.
j777j
03/7/2019
01:31
LONDON (Alliance News) - Shares in Futura Medical PLC plunged on Friday after it said that it raised GBP5.6 million via a share placing, subscription and an open offer at a discounted price. The company placed 80 million shares at 7 pence, a 28% discount to the closing price of 9.65p on Thursday. The new shares represent 37% of the company's enlarged share capital. Shares were trading down 27% at 7.00p, on Friday. On Thursday, Futura had said it would raise GBP6 million via an accelerated bookbuild and open offer, so it missed this mark by GBP400,000. The company had said it would issue at least 71.4 million shares. Just thought I'd have a go at repeating something too as that seems to be what goes on around here. Just for those who might have forgotten, although it wasn't that long ago. :-)
glavey
02/7/2019
22:46
Was looking back at previous newsflow where FUM presented at Nov 18 annual SMSNA meeting. The 2019 annual meeting is 23-27th Oct and could present an opportunity for the update. Would certainly be a great platform for this potential game changer.
k8 rhm
Chat Pages: 688  687  686  685  684  683  682  681  680  679  678  677  Older
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190824 07:07:05